Invest in

Biotech Breakthroughs

12.6%
1.4%
0.0%

Feeling Better About Biotech

The next big cure for a complex, scary disease is unlikely to come from old-school pharma. It’s likely coming from biotech. Scientists, investors, and patients are all banking on the $93 billion biotech industry.[1] It’s outpaced Big Pharma in finding treatments for cancer, AIDS, multiple sclerosis, and other diseases. The FDA approved 43 drugs in 2012, a 20% jump from the previous year.[4] Big Pharma has responded by snapping up promising biotech and smaller pharmaceutical companies, at lofty valuations, with premiums for several public companies in excess of 50%.[2] In fact, 2013 was a big year for the biotech industry, with $29B in M&A deals through the 1st half of 2013.[3] This motif includes only biotech companies with at least two years of cash flow to help screen out companies at greater risk of losing money. See more
12.6%
1.4%
0.0%
Invest in Thematic Portfolios
Create your own customizable basket of up to 30 stocks or ETFs for just $9.95.
Motif Index 1 YR Return
Biotech Breakthroughs Benchmark
With this Motif, you can buy the following basket of stocks for just $9.95:
Weight Segment & Stocks Symbol 1 MO / 1 YR Return
36.7% Cancer 1.7%
19.1% Amgen Inc. AMGN 9.1%
15.1% Celgene Corporation CELG 0.5%
1.5% Seattle Genetics Inc. SGEN 61.5%
1.0% SciClone Pharmaceuticals Inc. SCLN 11.3%
18.5% Other Diseases 33.9%
6.3% Regeneron Pharmaceuticals Inc. REGN 34.9%
5.6% Alexion Pharmaceuticals Inc. ALXN 33.4%
3.6% Vertex Pharmaceuticals Incorporated VRTX 38.9%
2.0% United Therapeutics Corporation UTHR 18.0%
1.0% Acorda Therapeutics Inc. ACOR 45.1%
17.7% Infectious Diseases 26.3%
15.3% Gilead Sciences Inc. GILD 28.2%
1.3% Opko Health Inc. OPK 2.2%
1.0% Emergent Biosolutions Inc. EBS 28.1%
17.4% Autoimmune Disorders 5.6%
10.2% Biogen Inc. BIIB 1.1%
3.1% Incyte Corporation INCY 7.4%
3.0% BioMarin Pharmaceutical Inc. BMRN 15.2%
1.0% Rigel Pharmaceuticals Inc. RIGL 16.4%
9.8% Research & Diagnostics 7.5%
3.2% Illumina Inc. ILMN 32.9%
2.8% Bio-Techne Corp TECH 17.5%
2.7% Charles River Laboratories International Inc. CRL 4.3%
1.0% Meridian Bioscience Inc. VIVO 5.4%

Quotes delayed 15 mins. Currently Dec 9, 2016 6:36:48 AM. Fields are marked with -- when data is unavailable.